Chapter 19 – Amegakaryocytic Thrombocytopenia
暂无分享,去创建一个
[1] W. Alexander,et al. Functional characterization of c-Mpl ectodomain mutations that underlie congenital amegakaryocytic thrombocytopenia , 2014, Growth factors.
[2] R. Porcher,et al. Allogeneic hematopoietic stem cell transplantation in Fanconi anemia: the European Group for Blood and Marrow Transplantation experience. , 2013, Blood.
[3] M. Ballmaier,et al. Congenital amegakaryocytic thrombocytopenia (CAMT) presenting as severe pancytopenia in the first month of life , 2013, Pediatric blood & cancer.
[4] H. Yaish,et al. A neonate with congenital amegakaryocytic thrombocytopenia associated with a chromosomal microdeletion at 21q22.11 including the gene RUNX1 , 2013, Journal of Perinatology.
[5] P. Agrawal,et al. A de novo T73I Mutation in PTPN11 in a Neonate with Severe and Prolonged Congenital Thrombocytopenia and Noonan Syndrome , 2013, Neonatology.
[6] M. Aljurf,et al. Bone marrow versus peripheral blood as the stem cell source for sibling transplants in acquired aplastic anemia: survival advantage for bone marrow in all age groups , 2012, Haematologica.
[7] M. Ballmaier,et al. Congenital Amegakaryocytic Thrombocytopenia: Clinical Presentation, Diagnosis, and Treatment , 2011, Seminars in thrombosis and hemostasis.
[8] J. Fay,et al. Effect of stem cell source on outcomes after unrelated donor transplantation in severe aplastic anemia. , 2011, Blood.
[9] E. Gluckman,et al. Milestones in umbilical cord blood transplantation , 2011, British journal of haematology.
[10] A. Geddis. Congenital amegakaryocytic thrombocytopenia , 2011, Pediatric blood & cancer.
[11] E. Lanino,et al. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA working party , 2010, Haematologica.
[12] M. Ballmaier,et al. Advances in the understanding of congenital amegakaryocytic thrombocytopenia , 2009, British journal of haematology.
[13] A. Geddis. Congenital amegakaryocytic thrombocytopenia and thrombocytopenia with absent radii. , 2009, Hematology/oncology clinics of North America.
[14] B. Kerlin,et al. Congenital amegakaryocytic thrombocytopenia: The diagnostic importance of combining pathology with molecular genetics , 2008, Pediatric blood & cancer.
[15] T. Suda,et al. Thrombopoietin/MPL signaling regulates hematopoietic stem cell quiescence and interaction with the osteoblastic niche. , 2007, Cell stem cell.
[16] P. Noris,et al. Congenital amegakaryocytic thrombocytopenia: clinical and biological consequences of five novel mutations , 2007, Haematologica.
[17] M. Abecasis,et al. Congenital amegakaryocytic thrombocytopenia—Report of a new c‐mpl gene missense mutation , 2007, American journal of hematology.
[18] M. Ballmaier,et al. Congenital amegakaryocytic thrombocytopenia: a retrospective clinical analysis of 20 patients , 2005, British journal of haematology.
[19] K. Kaushansky,et al. The molecular mechanisms that control thrombopoiesis. , 2005, The Journal of clinical investigation.
[20] K. Ihara,et al. Successful bone marrow transplantation in a patient with c‐mpl‐mutated congenital amegakaryocytic thrombocytopenia from a carrier donor , 2005, Pediatric transplantation.
[21] J. Drachman. Inherited thrombocytopenia: when a low platelet count does not mean ITP. , 2004, Blood.
[22] M. Ballmaier,et al. c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. , 2001, Blood.
[23] Long T. Nguyen,et al. Amegakaryocytic thrombocytopenia and radio-ulnar synostosis are associated with HOXA11 mutation , 2000, Nature Genetics.
[24] M. Eguchi,et al. Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.
[25] D. Evans,et al. Cutaneous lymphangioma and amegakaryocytic thrombocytopenia in Noonan syndrome , 1991, Clinical genetics.
[26] Z. Estrov,et al. Congenital Amegakaryocytic Thrombocytopenia: An Intrinsic Hematopoietic Stem Cell Defect , 1990, The American journal of pediatric hematology/oncology.
[27] N. Bizzaro,et al. Neonatal Alloimmune Amegakaryocytosis: , 1988 .